We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-14.68%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$30.2B
AUM Growth
-$16.4B
(-35%)
Cap. Flow
-$9.03B
Cap. Flow
% of AUM
-29.95%
Top 10 Holdings %
Top 10 Hldgs %
24.78%
Holding
2,286
New
90
Increased
145
Reduced
1,551
Closed
496
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$38.4M |
| 2 |
VF Corp
VFC
|
+$38.2M |
| 3 |
Sherwin-Williams
SHW
|
+$37.3M |
| 4 |
Stanley Black & Decker
SWK
|
+$35.4M |
| 5 |
A.O. Smith
AOS
|
+$35.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1B |
| 2 |
Microsoft
MSFT
|
+$833M |
| 3 |
Amazon
AMZN
|
+$495M |
| 4 |
Tesla
TSLA
|
+$313M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.16% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Consumer Staples | 11.2% |
| 4 | Healthcare | 10.36% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Arlo Technologies
ARLO
$1.4B
| $76K | ﹤0.01% |
12,046
-6,724
| -36% | -$49.2K |
|
|
ESPR
1652
DELISTED
Esperion Therapeutics
ESPR
| $76K | ﹤0.01% |
11,992
-5,340
| -31% | -$30.3K |
|
1653
Planet Labs
PL
$7.3B
| $76K | ﹤0.01% |
+17,469
| New | +$90.2K |
|
|
SLGC
1654
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $76K | ﹤0.01% |
+16,812
| New | +$100K |
|
|
CPRX
1655
DELISTED
Catalyst Pharmaceutical
CPRX
| $75K | ﹤0.01% |
10,763
-7,445
| -41% | -$54.6K |
|
1656
Inovio Pharmaceuticals
INO
$79.8M
| $74K | ﹤0.01% |
3,544
-1,501
| -30% | -$42.3K |
|
1657
Paysafe
PSFE
$407M
| $74K | ﹤0.01% |
+3,166
| New | +$102K |
|
1658
RPC Inc
RES
$1.24B
| $72K | ﹤0.01% |
10,372
-4,748
| -31% | -$45.3K |
|
|
EQRX
1659
DELISTED
EQRx, Inc. Common Stock
EQRX
| $72K | ﹤0.01% |
+15,361
| New | +$69.2K |
|
1660
ADMA Biologics
ADMA
$1.92B
| $71K | ﹤0.01% |
36,170
+15,905
| +78% | +$31.3K |
|
|
NVTA
1661
DELISTED
Invitae Corporation
NVTA
| $71K | ﹤0.01% |
29,318
-13,009
| -31% | -$57.5K |
|
1662
Acco Brands
ACCO
$369M
| $70K | ﹤0.01% |
10,634
-6,842
| -39% | -$49.9K |
|
|
BORR
1663
Borr Drilling
BORR
$1.31B
| $70K | ﹤0.01% |
+15,097
| New | +$75K |
|
1664
SiriusPoint
SPNT
$2.98B
| $70K | ﹤0.01% |
12,832
-6,767
| -35% | -$40.6K |
|
1665
Community Health Systems
CYH
$385M
| $67K | ﹤0.01% |
17,682
-9,996
| -36% | -$70.4K |
|
1666
Karyopharm Therapeutics
KPTI
$168M
| $66K | ﹤0.01% |
983
-437
| -31% | -$40.1K |
|
|
DO
1667
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $66K | ﹤0.01% |
+11,222
| New | +$83.9K |
|
1668
Yext
YEXT
$501M
| $65K | ﹤0.01% |
13,499
-7,922
| -37% | -$44K |
|
|
DM
1669
DELISTED
Desktop Metal, Inc.
DM
| $65K | ﹤0.01% |
2,971
-541
| -15% | -$15.8K |
|
1670
Arbutus Biopharma
ABUS
$865M
| $64K | ﹤0.01% |
23,713
-7,367
| -24% | -$18.9K |
|
1671
indie Semiconductor
INDI
$733M
| $64K | ﹤0.01% |
+11,210
| New | +$77.2K |
|
1672
TG Therapeutics
TGTX
$8.58B
| $64K | ﹤0.01% |
14,963
-9,332
| -38% | -$58.3K |
|
1673
AvePoint
AVPT
$2.6B
| $63K | ﹤0.01% |
+14,469
| New | +$73.5K |
|
1674
Hims & Hers Health
HIMS
$6.5B
| $62K | ﹤0.01% |
+13,634
| New | +$58.2K |
|
1675
Helix Energy Solutions
HLX
$1.46B
| $62K | ﹤0.01% |
20,157
-11,625
| -37% | -$50.3K |
|
Similar funds
ProShare Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, ProShare Advisors held 2,286 positions worth $30.2B, down 35% from $46.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors withdrew a net $9.03B in Q2 2022, closing 496 positions and reducing 1,551 holdings. Its most notable exit was People's United Financial Inc, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in Peoples Bancorp worth $8.14M.
- ProShare Advisors's largest Q2 2022 buy was Peoples Bancorp: 305,862 shares worth $8.14M.
- ProShare Advisors added most to Pentair in Q2 2022, an estimated $38.4M increase.
- ProShare Advisors's biggest Q2 2022 reduction was Apple, cutting an estimated $1B.
- ProShare Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $163M.
- ProShare Advisors's ten largest holdings make up 25% of its $30.2B portfolio in Q2 2022.
- ProShare Advisors opened 90 new positions and closed 496 in Q2 2022.
- ProShare Advisors's portfolio value fell 35% quarter-over-quarter to $30.2B.
Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.